Collegium Pharmaceutical (COLL) EBIT Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 894.62 Mn | 745.30 Mn | 110.29 Mn | -89.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89.47% |
| Mar 31, 2026 | 42.46% |
| Dec 31, 2025 | 59.42% |
| Sep 30, 2025 | 78.21% |
| Jun 30, 2025 | -26.05% |
| Mar 31, 2025 | -56.16% |
| Dec 31, 2024 | -38.22% |
| Sep 30, 2024 | -22.60% |
| Jun 30, 2024 | 33.22% |
| Mar 31, 2024 | 100.89% |
| Dec 31, 2023 | 424.69% |
| Sep 30, 2023 | 119.93% |
| Jun 30, 2023 | 220.73% |
| Mar 31, 2023 | 345.90% |
| Dec 31, 2022 | 134.46% |
| Sep 30, 2022 | 44.65% |
| Jun 30, 2022 | -32.29% |
| Mar 31, 2022 | -147.26% |
| Dec 31, 2021 | -327.54% |
| Sep 30, 2021 | -27.91% |